1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROSENSE THERAPEUTICS LTD
NeuroSense Therapeutics Ltd
XNAS: NRSN
0.35 0.02 (6.06%)
223.9K
XNAS Volume

XNAS 11 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Split
NeuroSense Therapeutics Ltd has split the face value of its shares from $1 to $20 on 14 Sep 2026. See details


Insider Trading disclosures for NeuroSense Therapeutics Ltd

There were no Insider Trade disclosures made for NeuroSense Therapeutics Ltd

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures